Guidelines for radioiodinated MIBG scintigraphy in children

@article{Olivier2003GuidelinesFR,
  title={Guidelines for radioiodinated MIBG scintigraphy in children},
  author={Pierre Olivier and Paula Colarinha and Jure Fettich and Sibylle Fischer and J{\"o}rgen Fr{\"o}kier and Francesco Giammarile and Isky Gordon and Klaus Hahn and Levent Kabasakal and Mike Mann and Mercedes Mitjavila and Amy Piepsz and Ute Porn and Rune Sixt and Jeannette van Velzen},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2003},
  volume={30},
  pages={B45-B50},
  url={https://api.semanticscholar.org/CorpusID:20350450}
}
These guidelines on the use of radioiodinated 99mTc-MIBG scintigraphy in children, which summarise the views of the Paediatric Committee of the European Association of Nuclear Medicine, provide a

131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

The present guidelines have been prepared for nuclear medicine physicians and intend to offer assistance in optimizing the diagnostic information that can currently be obtained from mIBG scintigraphy.

131I/123I-Metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging

The present guidelines have been prepared for nuclear medicine physicians and are intended to offer assistance in optimising the diagnostic information that can currently be obtained from MIBG scintigraphy.

Radionuclide Imaging of Children

In this chapter, the common nuclear medicine procedures in children are reviewed, focusing on the indication of the study, patient preparation, dose of the radioactivity, and the interpretation of the studies.

Guidelines on nuclear medicine imaging in neuroblastoma

These EANM guidelines include updated information on 123I-mIBG, the most common study in nuclear medicine for the evaluation of neuroblastoma, and on PET/CT imaging with 18F-FDG,18F-DOPA and 68Ga-DOTA peptides.

99mTc-HYNIC octreotide in neuroblastoma

99mTc-HYNIC-octreotide may be a promising radiopharmaceutical for the evaluation of neuroblastoma patients and justifies the pre liminary evaluation of this tracer in the context of a clinical trial.

Nuclear Medicine in Pediatric and Adolescent Tumors.

The literature on the use of radionuclide imaging and therapy in pediatric population with thyroid cancer, sarcomas, lymphoma, and NB, and F-18 DOPA scintigraphy provides the advantages of PET/CT imaging with early and short imaging times, high spatial resolution, inherent morphologic correlation with CT, and quantitation.

MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.

This review focuses on the use of MIBG and octreotide in the diagnosis and treatment of solid tumors that affect children and young adults.

Recognition of Abnormal Uptake through 123I-mIBG Scintigraphy Entropy for Paediatric Neuroblastoma Identification

A computerized method that processes an image and calculates a quantitative measurement considered as its entropy, suitable for the identification of abnormal uptake regions, for which there is enough suspicion that they may be a tumour or metastatic site is presented.
...

A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine.

The Paediatric Task Group of the European Association of Nuclear Medicine has investigated the current situation and now suggests a method for standardization of administered amounts of radiopharmaceutical in paediatrics.

Current concepts on the diagnostic use of MIBG in children.

The radioisotopes available for labeling of MIBG and related compounds, the dosimetry, metabolism and mechanisms of uptake and retention, and comparisons with other radiotracers available for imaging neuroblastomas are addressed.

Refining interpretation of MIBG scans in children.

A number of important physiological areas of uptake in soft tissues can lead to false-positive interpretations of normal scans, such as the physiological upper thoracic uptake which has never been previously described.

Consolidating the role of*I-MIBG-scintigraphy in childhood neuroblastoma: Five years of clinical experience

I-MIBG-scintigraphy makes it possible to define the nature of the tumour, particularly in cases with normal catecholamine levels; to establish how extensive the lesions are at the time of diagnosis; and to confirm complete remission.

[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.

SPECT imaging compared to planar scanning can demonstrate a greater number of lesions, and seems to be indicated mainly in cases in which diagnostic assessment is difficult, such as small residual tumors or in the follow up of children no longer in therapy.

Efficacy of Metaiodobenzylguanidine as a Scintigraphic Agent for the Detection of Neuroblastoma

This study suggests that MIBG is the more efficacious agent for the scintigraphic evaluation of neuroblastoma.

Nuclear medicine imaging of pheochromocytoma and neuroblastoma.

Scintigraphy with MIBG has become an indispensable diagnostic method for defining the extent and location of many if not most pheochromocytomas and neuroblastomas.

Specificity of radioiodinated MIBG for neural crest tumors in childhood.

MIBG scintigraphy is highly specific for neuroblastoma and pheochromocytoma and only 4% of nonsympathomedullary tumors in childhood showed MIBG uptake, of which only 2% were of non-neural crest origin.

Upper clavicular and cardiac meta-[123I]iodobenzylguanidine uptake in children.

In order to clarify some of the particularities and pitfalls of the MIBG thoracic scan, we report our experience with 5 children with Stage III or IV neuroblastoma who presented equivocal scans. The